Page last updated: 2024-10-27

gabapentin and Delirium of Mixed Origin

gabapentin has been researched along with Delirium of Mixed Origin in 15 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research Excerpts

ExcerptRelevanceReference
"Although postoperative opioid use was reduced, perioperative administration of gabapentin did not result in a reduction of postoperative delirium or hospital length of stay."9.24Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial. ( Ames, C; Berven, S; Bozic, K; Burch, S; Chang, S; Chen, N; Chou, D; Covinsky, K; Deviren, V; Kinjo, S; Kramer, JH; Leung, JM; Meckler, G; Newman, S; Ries, M; Sands, LP; Tay, B; Tsai, T; Vail, T; Voss, V; Weinstein, P; Youngblom, E, 2017)
"In this randomized pilot clinical trial, the authors tested the hypothesis that using gabapentin as an add-on agent in the treatment of postoperative pain reduces the occurrence of postoperative delirium."9.12Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. ( Ames, C; Chou, D; Dahl, JB; Leung, JM; Petersen, KL; Rico, M; Rowbotham, MC; Sands, LP; Weinstein, P, 2006)
"Gabapentin (Neurontin) is approved by the US Food and Drug Administration for treatment of epilepsy and post-herpetic neuralgia."7.75Gabapentin-induced delirium and dependence. ( Kahn, DA; Kruszewski, SP; Paczynski, RP, 2009)
"Although postoperative opioid use was reduced, perioperative administration of gabapentin did not result in a reduction of postoperative delirium or hospital length of stay."5.24Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial. ( Ames, C; Berven, S; Bozic, K; Burch, S; Chang, S; Chen, N; Chou, D; Covinsky, K; Deviren, V; Kinjo, S; Kramer, JH; Leung, JM; Meckler, G; Newman, S; Ries, M; Sands, LP; Tay, B; Tsai, T; Vail, T; Voss, V; Weinstein, P; Youngblom, E, 2017)
"In this randomized pilot clinical trial, the authors tested the hypothesis that using gabapentin as an add-on agent in the treatment of postoperative pain reduces the occurrence of postoperative delirium."5.12Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. ( Ames, C; Chou, D; Dahl, JB; Leung, JM; Petersen, KL; Rico, M; Rowbotham, MC; Sands, LP; Weinstein, P, 2006)
"In this cohort study, perioperative gabapentin use was associated with increased risk of delirium, new antipsychotic use, and pneumonia among older patients after major surgery."4.12Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery. ( Bateman, BT; Inouye, SK; Kim, DH; Lee, SB; Levin, R; Lie, JJ; Marcantonio, ER; Metzger, E; Park, CM, 2022)
"Gabapentin (Neurontin) is approved by the US Food and Drug Administration for treatment of epilepsy and post-herpetic neuralgia."3.75Gabapentin-induced delirium and dependence. ( Kahn, DA; Kruszewski, SP; Paczynski, RP, 2009)
"Delirium is a very common and serious disorder with high morbidity and mortality."2.45Pharmacological treatment for the prevention of delirium: review of current evidence. ( Howard, R; Tabet, N, 2009)
"Gabapentin is a second generation anticonvulsant that is effective in the treatment of chronic neuropathic pain."2.44Gabapentin: a multimodal perioperative drug? ( Irwin, MG; Kong, VK, 2007)
"Infant delirium is an under-recognized clinical entity in neonatal intensive care, and earlier identification and treatment could minimize morbidities associated with this condition."1.46A case of infant delirium in the neonatal intensive care unit. ( Bidegain, M; Cotten, CM; Edwards, LE; Hornik, CD; Hutchison, LB; Smith, PB, 2017)
"Delirium is still one of the most common and distressing symptoms in palliative care patients."1.38Reversible delirium in an advanced cancer patient. ( Jagsch, C; Kierner, KA; Watzke, HH, 2012)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (26.67)29.6817
2010's8 (53.33)24.3611
2020's3 (20.00)2.80

Authors

AuthorsStudies
Hilbert, MT1
Henkel, ND1
Spetz, SL1
Malaiyandi, DP1
Park, CM1
Inouye, SK1
Marcantonio, ER1
Metzger, E1
Bateman, BT1
Lie, JJ1
Lee, SB1
Levin, R1
Kim, DH1
Gupta, A1
Joshi, P1
Bhattacharya, G1
Lehman, M1
Funaro, M1
Tampi, DJ1
Tampi, RR1
Leung, JM2
Sands, LP2
Chen, N1
Ames, C2
Berven, S1
Bozic, K1
Burch, S1
Chou, D2
Covinsky, K1
Deviren, V1
Kinjo, S1
Kramer, JH1
Ries, M1
Tay, B1
Vail, T1
Weinstein, P2
Chang, S1
Meckler, G1
Newman, S1
Tsai, T1
Voss, V1
Youngblom, E1
Regan, DW1
Kashiwagi, D1
Dougan, B1
Sundsted, K1
Mauck, K1
Di Fabio, R1
D'Agostino, C1
Baldi, G1
Pierelli, F1
Salman, AE1
Camkıran, A1
Oğuz, S1
Dönmez, A1
Dighe, K1
Clarke, H1
McCartney, CJ1
Wong, CL1
Lee, YI1
Chen, L1
Smith, RL1
Edwards, LE1
Hutchison, LB1
Hornik, CD1
Smith, PB1
Cotten, CM1
Bidegain, M1
Tabet, N1
Howard, R1
Kruszewski, SP1
Paczynski, RP1
Kahn, DA1
Kierner, KA1
Jagsch, C1
Watzke, HH1
Rico, M1
Petersen, KL1
Rowbotham, MC1
Dahl, JB1
Kong, VK1
Irwin, MG1

Clinical Trials (7)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain in Surgical Patients[NCT00221338]Phase 3750 participants (Actual)Interventional2006-01-31Completed
The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study Prior to a Larger Randomized Controlled Trial[NCT02200172]Phase 260 participants (Actual)Interventional2014-12-31Completed
A Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety and Efficacy of the Perioperative Administration of Pregabalin in Reducing the Incidence of Postoperative Delirium and Improving Acute Postoperative Pain Management[NCT00819988]Phase 3240 participants (Actual)Interventional2009-05-31Completed
Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)[NCT01700816]40 participants (Actual)Interventional2012-10-31Terminated (stopped due to Low incidence of delirium.)
The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair[NCT02419443]Phase 4100 participants (Anticipated)Interventional2011-08-31Active, not recruiting
Effect of Preoperative Pregabalin on Propofol Induction Dose[NCT01158859]Phase 450 participants (Anticipated)Interventional2010-04-30Completed
The Effect of Gabapentin on Acute Pain and PONV in Bariatric Surgical Patients[NCT00886236]62 participants (Actual)Interventional2008-02-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Hospital Length of Stay

(NCT00221338)
Timeframe: Typically within the first week after surgery

Interventiondays (Mean)
Gabapentin4.4
Placebo4.1

Incidence of Postoperative Delirium by Study Group

Number of subjects who developed postoperative delirium, as measured by the Confusion Assessment Method, a validated tool for assessing delirium based on DSM-III-R, on any of the first three postoperative days. (NCT00221338)
Timeframe: postoperative days 1, 2 and 3

InterventionParticipants (Count of Participants)
Gabapentin84
Placebo72

Median Postoperative Opioid Doses Across Study Follow up Period

Postoperative intravenous opioid doses converted to morphine equivalents. Median derived from total opioid doses on first, second and third postoperative days. (NCT00221338)
Timeframe: Study follow up period: postoperative days 1, 2 and 3

Interventionmorphine equivalents, mg (Median)
Gabapentin6.7
Placebo6.7

Postoperative Pain Score - Postoperative Day 1

Postoperative pain as measured by Visual Analog Pain scale (0=no pain, 10=worst pain imaginable). (NCT00221338)
Timeframe: Postoperative day 1

Interventionscore on a scale (Mean)
Gabapentin4
Placebo4

Postoperative Pain Score - Postoperative Day 2

Postoperative pain as measured by Visual Analog Pain scale (0=no pain, 10=worst pain imaginable). (NCT00221338)
Timeframe: Postoperative day 2

Interventionscore on a scale (Mean)
Gabapentin3
Placebo4

Postoperative Pain Score - Postoperative Day 3

Postoperative pain as measured by Visual Analog Pain scale (0=no pain, 10=worst pain imaginable). (NCT00221338)
Timeframe: Postoperative day 3

Interventionscore on a scale (Mean)
Gabapentin3
Placebo3

Hematocrit (HCT)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

Interventionvolume percentage (vol%) of red blood ce (Median)
Bright Light Therapy28.20
Sham Light26.70

Hemoglobin (HGB)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

Interventiong/dl (Median)
Bright Light Therapy9.70
Sham Light9.55

Hospital Length of Stay

(NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

Interventiondays (Median)
Bright Light Therapy18
Sham Light18.5

Number of Participants Who Developed Delirium Based on Meeting Criteria on the Delirium Rating Scale and/or Memorial Delirium Assessment Scale

Monday, Wednesday, and Friday assessments will begin after beginning light therapy and include the Delirium Rating Scale-Revised-98 (DRS-98)and Memorial Delirium Assessment Scale (MDAS) (NCT01700816)
Timeframe: From hospital admission until the date of first documented delirium, assessed up to 28 days post-transplant

InterventionParticipants (Count of Participants)
Bright Light Therapy1
Sham Light0

Platelet Count

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

Interventionthousand cells/uL (Median)
Bright Light Therapy39
Sham Light33.5

Red Blood Cells (RBC)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

InterventionM/uL (Median)
Bright Light Therapy3.21
Sham Light2.93

Severity of Delirium Episodes: Memorial Delirium Assessment Scale (MDAS)

"Monday, Wednesday, and Friday assessments of the Memorial Delirium Assessment Scale (MDAS); Patients will receive assessments after beginning light therapy until day 28 post-transplant or discharge, whichever comes first.~10 item scale Items are rated on a four-point scale from 0 (none) to 3 (severe) depending on the level of impairment, rendering a maximum possible score of 30.~A score of 13 has been recommended as a cut-off for establishing the diagnosis of delirium" (NCT01700816)
Timeframe: From first documented episode of delirium until discharge from the hospital, assessed up to 28 days post-transplant

Interventionunits on a scale (Number)
Bright Light Therapy18

White Blood Cells (WBC)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

InterventionK/uL (Median)
Bright Light Therapy2.30
Sham Light4.75

Serum Creatinine and Blood Urea Nitrogen (BUN)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT. (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

,
Interventionmg/dl (Median)
Serum CreatinineBlood Urea Nitrogen (BUN)
Bright Light Therapy0.669
Sham Light0.758.5

Sodium (Na), Potassium (K), Chloride (Cl), and Carbon Dioxide (CO2)

Lab values at latest available follow-up date per participant. These tests are performed as part of routine clinical care on patients undergoing HSCT (Hematopoietic Stem Cell Transplantation). (NCT01700816)
Timeframe: From admission to hospital to discharge, an expected average of 28 days post-transplant

,
Interventionmmol/L (Median)
Sodium (Na)Potassium (K)Chloride (Cl)Carbon Dioxide (CO2)
Bright Light Therapy1393.610524.9
Sham Light138.03.80103.025.10

Evaluate Incidence of Respiratory Depression as Evidenced by Pulse Oximetry Data

(NCT00886236)
Timeframe: 48 hours

Intervention% oxygen saturation (Mean)
1 Preoperative Gabapentin Liquid93
2 Preoperative and Postoperative Gabapentin Liquid94
3 Preoperative and Postoperative Placebo Liquid95

Evaluate the Amount of Diluadid Given Postoperatively

The amount of intraoperative and postoperative opioids used will be collected and analyzed for the three different arms. (NCT00886236)
Timeframe: 120 hours

Interventionml (Mean)
1 Preoperative Gabapentin Liquid11.035
2 Preoperative and Postoperative Gabapentin Liquid8.7
3 Preoperative and Postoperative Placebo Liquid12.4

Number of Participants Who Experience Incidence of Postoperative Nausea.

(NCT00886236)
Timeframe: 120 hours

InterventionParticipants (Count of Participants)
1 Preoperative Gabapentin Liquid12
2 Preoperative and Postoperative Gabapentin Liquid11
3 Preoperative and Postoperative Placebo Liquid12

Reviews

4 reviews available for gabapentin and Delirium of Mixed Origin

ArticleYear
Is there evidence for using anticonvulsants in the prevention and/or treatment of delirium among older adults?
    International psychogeriatrics, 2022, Volume: 34, Issue:10

    Topics: Aged; Anticonvulsants; Arthroplasty, Replacement, Hip; Delirium; Gabapentin; Humans; Pregabalin

2022
Update in perioperative medicine: practice changing evidence published in 2016.
    Hospital practice (1995), 2017, Volume: 45, Issue:4

    Topics: Amines; Analgesics; Anticoagulants; Antipsychotic Agents; Arthritis, Rheumatoid; Blood Transfusion;

2017
Pharmacological treatment for the prevention of delirium: review of current evidence.
    International journal of geriatric psychiatry, 2009, Volume: 24, Issue:10

    Topics: Amines; Anti-Inflammatory Agents; Anticonvulsants; Antipsychotic Agents; Central Nervous System Depr

2009
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007

Trials

4 trials available for gabapentin and Delirium of Mixed Origin

ArticleYear
Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial.
    Anesthesiology, 2017, Volume: 127, Issue:4

    Topics: Aged; Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Delirium; Double-Blind Me

2017
Gabapentin premedication for postoperative analgesia and emergence agitation after sevoflurane anesthesia in pediatric patients.
    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2013, Volume: 25, Issue:4

    Topics: Amines; Anesthesia, General; Anesthetics, Inhalation; Anti-Anxiety Agents; Child; Child, Preschool;

2013
Perioperative gabapentin and delirium following total knee arthroplasty: a post-hoc analysis of a double-blind randomized placebo-controlled trial.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2014, Volume: 61, Issue:12

    Topics: Aged; Amines; Analgesics; Arthroplasty, Replacement, Knee; Cyclohexanecarboxylic Acids; Delirium; Do

2014
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Delirium; Feasibility Studies; Female; Gabapentin;

2006

Other Studies

7 other studies available for gabapentin and Delirium of Mixed Origin

ArticleYear
The Rising Status of Phenobarbital: A Case for Use in Severe Refractory Hyperactive Poststroke Delirium.
    The neurologist, 2023, Mar-01, Volume: 28, Issue:2

    Topics: Antipsychotic Agents; Delirium; Gabapentin; Hospitalization; Humans; Male; Middle Aged; Phenobarbita

2023
Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery.
    JAMA internal medicine, 2022, 11-01, Volume: 182, Issue:11

    Topics: Aged; Antipsychotic Agents; Cohort Studies; Delirium; Female; Gabapentin; Hospital Mortality; Hospit

2022
Delirium after gabapentin withdrawal. Case report.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2013, Volume: 40, Issue:1

    Topics: Aged; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Delirium; Electroencephalography; Epilep

2013
Enigmatic Fever and Delirium in a Critically Ill Patient.
    Annals of the American Thoracic Society, 2015, Volume: 12, Issue:9

    Topics: Adult; Amines; Critical Illness; Cyclohexanecarboxylic Acids; Delirium; Fever; Gabapentin; gamma-Ami

2015
A case of infant delirium in the neonatal intensive care unit.
    Journal of neonatal-perinatal medicine, 2017, Volume: 10, Issue:1

    Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Cardiac Catheterization; Cyclohexanecarboxylic Acid

2017
Gabapentin-induced delirium and dependence.
    Journal of psychiatric practice, 2009, Volume: 15, Issue:4

    Topics: Adult; Amines; Analgesics, Non-Narcotic; Cyclohexanecarboxylic Acids; Delirium; Gabapentin; gamma-Am

2009
Reversible delirium in an advanced cancer patient.
    Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:1-2

    Topics: Amines; Analgesics; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, No

2012